G01N 2800/044
Hyperlipemia or hypolipemia
Official title: Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
G01N2800/044 (Hyperlipemia or hypolipemia) appears on 403 US grants and 568 published applications in this corpus.
Search patents in G01N- Granted patents
- 403
- Published applications
- 568
- Assignees
- 391
- Inventors
- 1,287
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 7 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 12 | 0 |
| 1999 | 9 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 1 |
| 2002 | 8 | 27 |
| 2003 | 10 | 33 |
| 2004 | 14 | 27 |
| 2005 | 13 | 31 |
| 2006 | 9 | 36 |
| 2007 | 19 | 30 |
| 2008 | 15 | 20 |
| 2009 | 16 | 36 |
| 2010 | 17 | 38 |
| 2011 | 11 | 27 |
| 2012 | 19 | 27 |
| 2013 | 17 | 21 |
| 2014 | 17 | 28 |
| 2015 | 13 | 16 |
| 2016 | 13 | 31 |
| 2017 | 8 | 11 |
| 2018 | 11 | 30 |
| 2019 | 15 | 20 |
| 2020 | 6 | 8 |
| 2021 | 9 | 17 |
| 2022 | 6 | 15 |
| 2023 | 7 | 8 |
| 2024 | 5 | 14 |
| 2025 | 5 | 6 |
| 2026 | 3 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation25 Aug 2026US 12,715,899 B2Seoul National University Hospital
- Methods for evaluating angiogenesis21 Apr 2026US 12,607,623 B2Washington University
- Methods and compositions for determining OxPL-associated diseases and disorders10 Mar 2026US 12,571,805 B2The Regents of the University of California
- Methods and materials for assessing and treating obesity18 Nov 2025US 12,474,353 B2Mayo Foundation for Medical Education and Research
- Method for measuring the trimethylamine n-oxide production capacity in an individual9 Sep 2025US 12,411,142 B2National Taiwan University
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- S100a7 as a diagnostic marker and therapeutic target for disorders23 Jul 2026US 2026/0209330 A1Ohio State Innovation Foundation
- Long non-coding rna lipter preserves lipid metabolism of the human heart16 Jul 2026US 2026/0201372 A1The Trustees of Indiana University
- Detection of risk of pre-eclampsia in obese pregnant women2 Jul 2026US 2026/0188518 A1Metabolomic Diagnostics Limited
- Methods of treating lipedema including akr1c1 as a therapeutic target25 Jun 2026US 2026/0174776 A1Magi Euregio Scs
Most cited
By later US patents
- Polarographic analysis of cholesterol and other macromolecular substances381US 4,040,908 AChildren's Hospital Medical Center · 1977
- Method and apparatus for measuring classes and subclasses of lipoproteins153US 5,343,389 ANorth Carolina State University · 1994
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998
- Inhibitors of microsomal triglyceride transfer protein and method129US 5,739,135 ABristol-Myers Squibb Company · 1998
- Nucleic acids encoding microsomal trigyceride transfer protein128US 5,595,872 ABristol-Myers Squibb Company · 1997